Cantor Cuts Charlotte's Web Target On Lowered Sales Estimates

Shares of Charlotte's Web Holdings Inc CWBHF are down 20% over the last three months and while regulatory outlook seems to be improving, near-term concerns remain.

Cantor Fitzgerald analyst Pablo Zuanic maintained a Neutral rating for Charlotte's Web, while reducing the price target from $5.85 to $5.25.

The Charlotte's Web Thesis

Concerns around the company’s near-term prospects stem from a potential second-quarter miss and the proforma guidance being set below consensus expectations, Zuanic said.

He expects Charlotte's Web to report its second-quarter sales around 10% below the current consensus estimate.

Although management is unlikely to trim fiscal 2020 guidance for the base business this early, expectations from the Abacus acquisition seems unrealistic at $25 million, the analyst added. 

Despite the near-term concerns, Zuanic believes Charlotte's Web is “a much stronger company” after the acquisition of Abacus, given its market penetration in CBD (cannabidiol) topicals and as regulations become clearer.

While the FDA seems to be moving in the right direction, its draft of guidelines submitted to the White House has been termed as “not economically significant” and has no legal deadline, suggesting that the document may be missing “the key features sought by the industry,” the analyst wrote.

CWBHF Price Action: Shares of Charlotte's Web were trading around $3.76 at the time of publication.

Related Links
Two Large Financing Deals Lift Cannabis Capital Raises Above $2.5B For 2020
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorCannabisPenny StocksPrice TargetReiterationMarketsAnalyst RatingsCantor FitzgeraldPablo Zuanic
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...